William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
GenMark Diagnostics (GNMK) Prices 7.254M Share Common Offering at $9.65/Sh
-
GenMark Prices Public Offering of Common Stock
-
GenMark Prices Public Offering of Common Stock
-
GenMark Diagnostics (GNMK) to Offer Common Stock
-
GenMark Commences Public Offering of Common Stock
-
GenMark Commences Public Offering of Common Stock
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
-
GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
-
GenMark Diagnostics (GNMK) Prices 6.38M Share Upsized Offering at $11.75/Sh
-
GenMark Diagnostics Prices Upsized Public Offering of Common Stock
-
GenMark Diagnostics to Present at the 2017 William Blair Growth Stock Conference
-
GenMark Diagnostics to Present at the William Blair 36th Annual Growth Stock Conference
-
GenMark Diagnostics to Present at the William Blair 35th Annual Growth Stock Conference
-
GenMark (GNMK) Prices Upsized 7.6M Offering at $9.84/Share
-
Notable Analyst Rating Changes 07/12: QCOM, MSFT, YHOO, SNDK Upgraded; ACXM, GLW, MAR, MOLX Downgraded
-
William Blair Initiates Coverage on GenMark Diagnostics (GNMK) with an Outperform
-
GenMark Diagnostics (GNMK) Prices 4.6M IPO at $6.00/Share

